Orchid Pharma licenses antibiotic Exblifep to Russia’s Pharmasyntez
Mumbai: Chennai-based Orchid Pharma has out-licensed its novel antibiotic Exblifep (cefepime/enmetazobactam ), Russia market commercial rights to Pharmasyntez. Under the agreement, Pharmasyntez will hold the exclusive rights to register and …